Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?
European Respiratory Journal · 2026-05 · 67 (5) · 2600012
DOI: 10.1183/13993003.00012-2026 ↗Kurz gefasst
Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 21.05.2026. Verfasst von James D Chalmers und 22 weiteren Autor:innen. Beteiligte Einrichtung: Radcliffe Department of Medicine, University of Oxford, Oxford, UK james.chalmers@rdm.ox.ac.uk. Die Arbeit nennt 14 Literaturangaben. Gefördert von: European Respiratory Society.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Radcliffe Department of Medicine, University of Oxford, Oxford, UK james.chalmers@rdm.ox.ac.uk.
- Royal Papworth Hospital NHS Foundation Trust and University of Cambridge, Cambridge, UK.
- Medical University of South Carolina, Charleston, SC, USA.
- Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
- Department of Respiratory Medicine and French Cystic Fibrosis National Reference Center, Hôpital Cochin, AP-HP and Université Paris Cité, Inserm U1016, Institut Cochin, Paris, France.
- 5th Respiratory Department and Bronchiectasis Unit, "Sotiria" General Hospital of Chest Diseases, Athens, Greece.
ORCID-Profile: Pierre Régis Burgel, Francesco Blasi, Beatriz Herrero Cortina, Sanjay H Chotirmall, Felix C Ringshausen, Lucy Morgan, Mattia Nigro, Natalie Lorent, Michal Shteinberg, Stefano Aliberti
Förderung
- European Respiratory Society
Zitieren
APA
Chalmers, J. D., Haworth, C. S., Flume, P., Long, M. B., Burgel, P. R., Dimakou, K., Blasi, F., Herrero Cortina, B., Dhar, R., Chotirmall, S. H., Ringshausen, F. C., Altenburg, J., Morgan, L., Nigro, M., Sibila, O., McShane, P. J., Winthrop, K., Loebinger, M. R., Lorent, N., …, & Aliberti, S. (2026). Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?. European Respiratory Journal, 67(5), 2600012. https://doi.org/10.1183/13993003.00012-2026
Vancouver
Chalmers JD, Haworth CS, Flume P, Long MB, Burgel PR, Dimakou K, et al. Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?. European Respiratory Journal. 2026;67(5):2600012. doi:10.1183/13993003.00012-2026
BibTeX
@article{Chalmers2026,
author = {Chalmers, James D and Haworth, Charles S and Flume, Patrick and Long, Merete B and Burgel, Pierre Régis and Dimakou, Katerina and Blasi, Francesco and Herrero Cortina, Beatriz and Dhar, Raja and Chotirmall, Sanjay H and Ringshausen, Felix C and Altenburg, Josje and Morgan, Lucy and Nigro, Mattia and Sibila, Oriol and McShane, Pamela J and Winthrop, Kevin and Loebinger, Michael R and Lorent, Natalie and Goeminne, Pieter and Shteinberg, Michal and Polverino, Eva and Aliberti, Stefano},
title = {Mucoactive therapies and the European Respiratory Society guideline for adult bronchiectasis: what now after the CLEAR trial?},
journal = {European Respiratory Journal},
year = {2026},
volume = {67},
number = {5},
pages = {2600012},
doi = {10.1183/13993003.00012-2026}
}
EUVIMED